Lexicon Pharmaceuticals | LXRX - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Abbott USD 11.22B 655M 2026-03
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 23.48B 2.3B 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Illumina USD 764M 26M 2026-06
Insmed USD 215.32M 36.77M 2026-06
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 22.54B 1.21B 2026-03
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
MacroGenics USD 10.42M 2.95M 2026-03
MannKind USD 43.21M 15.07M 2026-06
Merck USD 12.21B 435M 2026-03
Moderna USD 17M 54M 2026-06
Novartis USD 9.85B 252M 2026-06
PTC Therapeutics USD 219.92M 38.3M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 310.3M 1.7M 2026-06
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12